Floatz logo

Pregabalin

Dexmedetomidine

Peking University First HospitalSmall moleculePhase 4 / ApprovedActive
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Dexmedetomidine cohort.

Asset / SponsorPhaseRating
Bxcl501
Peking University First Hospital
Phase 4BBB
S-Ketamine
Peking University First Hospital
Phase 4BB
Amitriptyline
Peking University First Hospital
Phase 4BB
SUFENTANYL
Peking University First Hospital
Phase 4BB
Zofran
Peking University First Hospital
Phase 4BB

View all 21 →

Same molecule, other indications

Pregabalin is also rated in:

neuralgiaDormant
A
Indicative ·
82 / 100
View asset →
peripheral neuropathyDormant
A
Indicative ·
82 / 100
View asset →
focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →